ABBOTT LABORATORIES (ABL.DE) Stock Fundamental Analysis
FRA:ABL - Deutsche Boerse Ag - US0028241000 - Common Stock - Currency: EUR
Taking everything into account, ABL scores 6 out of 10 in our fundamental rating. ABL was compared to 57 industry peers in the Health Care Equipment & Supplies industry. ABL gets an excellent profitability rating and is at the same time showing great financial health properties. ABL has a decent growth rate and is not valued too expensively. This makes ABL very considerable for quality investing!
1. Profitability
1.1 Basic Checks
In the past year ABL was profitable.
ABL had a positive operating cash flow in the past year.
In the past 5 years ABL has always been profitable.
Each year in the past 5 years ABL had a positive operating cash flow.
1.2 Ratios
ABL's Return On Assets of 16.58% is amongst the best of the industry. ABL outperforms 92.98% of its industry peers.
The Return On Equity of ABL (27.66%) is better than 96.49% of its industry peers.
ABL has a better Return On Invested Capital (9.27%) than 78.95% of its industry peers.
ABL had an Average Return On Invested Capital over the past 3 years of 10.45%. This is above the industry average of 8.12%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.58% | ||
| ROE | 27.66% | ||
| ROIC | 9.27% |
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
1.3 Margins
ABL has a Profit Margin of 31.89%. This is amongst the best in the industry. ABL outperforms 98.25% of its industry peers.
ABL's Profit Margin has improved in the last couple of years.
The Operating Margin of ABL (17.45%) is better than 78.95% of its industry peers.
ABL's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 56.10%, ABL is in line with its industry, outperforming 52.63% of the companies in the same industry.
In the last couple of years the Gross Margin of ABL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.45% | ||
| PM (TTM) | 31.89% | ||
| GM | 56.1% |
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
2. Health
2.1 Basic Checks
ABL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for ABL remains at a similar level compared to 1 year ago.
The number of shares outstanding for ABL has been reduced compared to 5 years ago.
Compared to 1 year ago, ABL has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 5.99 indicates that ABL is not in any danger for bankruptcy at the moment.
The Altman-Z score of ABL (5.99) is better than 89.47% of its industry peers.
The Debt to FCF ratio of ABL is 1.99, which is an excellent value as it means it would take ABL, only 1.99 years of fcf income to pay off all of its debts.
ABL has a better Debt to FCF ratio (1.99) than 85.96% of its industry peers.
A Debt/Equity ratio of 0.26 indicates that ABL is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.26, ABL perfoms like the industry average, outperforming 57.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 1.99 | ||
| Altman-Z | 5.99 |
ROIC/WACC1.07
WACC8.69%
2.3 Liquidity
ABL has a Current Ratio of 1.78. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
ABL has a Current ratio of 1.78. This is comparable to the rest of the industry: ABL outperforms 52.63% of its industry peers.
A Quick Ratio of 1.27 indicates that ABL should not have too much problems paying its short term obligations.
ABL has a better Quick ratio (1.27) than 61.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.78 | ||
| Quick Ratio | 1.27 |
3. Growth
3.1 Past
ABL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.88%, which is quite good.
Measured over the past 5 years, ABL shows a small growth in Earnings Per Share. The EPS has been growing by 7.59% on average per year.
ABL shows a small growth in Revenue. In the last year, the Revenue has grown by 5.00%.
Measured over the past years, ABL shows a small growth in Revenue. The Revenue has been growing by 5.63% on average per year.
EPS 1Y (TTM)8.88%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%11.22%
Revenue 1Y (TTM)5%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%3.95%
3.2 Future
The Earnings Per Share is expected to grow by 9.82% on average over the next years. This is quite good.
Based on estimates for the next years, ABL will show a small growth in Revenue. The Revenue will grow by 7.19% on average per year.
EPS Next Y11.61%
EPS Next 2Y10.91%
EPS Next 3Y10.72%
EPS Next 5Y9.82%
Revenue Next Year6.43%
Revenue Next 2Y7.08%
Revenue Next 3Y7.24%
Revenue Next 5Y7.19%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 27.51 indicates a quite expensive valuation of ABL.
Based on the Price/Earnings ratio, ABL is valued a bit cheaper than the industry average as 73.68% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.41. ABL is around the same levels.
ABL is valuated rather expensively with a Price/Forward Earnings ratio of 22.88.
Based on the Price/Forward Earnings ratio, ABL is valued a bit cheaper than 61.40% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.19, ABL is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.51 | ||
| Fwd PE | 22.88 |
4.2 Price Multiples
ABL's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, ABL is valued a bit cheaper than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.35 | ||
| EV/EBITDA | 22.23 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ABL has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.37
PEG (5Y)3.63
EPS Next 2Y10.91%
EPS Next 3Y10.72%
5. Dividend
5.1 Amount
ABL has a Yearly Dividend Yield of 1.77%. Purely for dividend investing, there may be better candidates out there.
ABL's Dividend Yield is rather good when compared to the industry average which is at 2.27. ABL pays more dividend than 80.70% of the companies in the same industry.
Compared to the average S&P500 Dividend Yield of 2.35, ABL is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.77% |
5.2 History
On average, the dividend of ABL grows each year by 11.40%, which is quite nice.
Dividend Growth(5Y)11.4%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
28.92% of the earnings are spent on dividend by ABL. This is a low number and sustainable payout ratio.
The dividend of ABL is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP28.92%
EPS Next 2Y10.91%
EPS Next 3Y10.72%
FRA:ABL (7/11/2025, 7:00:00 PM)
112.5
-2.46 (-2.14%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners80.44%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap195.73B
Analysts78.18
Price Target126.16 (12.14%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.77% |
Yearly Dividend1.89
Dividend Growth(5Y)11.4%
DP28.92%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.21%
Min EPS beat(2)-1.16%
Max EPS beat(2)0.73%
EPS beat(4)2
Avg EPS beat(4)0.36%
Min EPS beat(4)-1.16%
Max EPS beat(4)2.22%
EPS beat(8)5
Avg EPS beat(8)0.86%
EPS beat(12)9
Avg EPS beat(12)5.62%
EPS beat(16)13
Avg EPS beat(16)9.57%
Revenue beat(2)0
Avg Revenue beat(2)-1.35%
Min Revenue beat(2)-1.37%
Max Revenue beat(2)-1.33%
Revenue beat(4)0
Avg Revenue beat(4)-0.95%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)-0.19%
Revenue beat(8)2
Avg Revenue beat(8)-0.01%
Revenue beat(12)6
Avg Revenue beat(12)1.49%
Revenue beat(16)10
Avg Revenue beat(16)3.05%
PT rev (1m)-0.1%
PT rev (3m)-2.56%
EPS NQ rev (1m)0.15%
EPS NQ rev (3m)0.18%
EPS NY rev (1m)0.05%
EPS NY rev (3m)0.22%
Revenue NQ rev (1m)0.1%
Revenue NQ rev (3m)0.82%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)0.74%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.51 | ||
| Fwd PE | 22.88 | ||
| P/S | 5.4 | ||
| P/FCF | 34.35 | ||
| P/OCF | 25.55 | ||
| P/B | 4.68 | ||
| P/tB | 11.92 | ||
| EV/EBITDA | 22.23 |
EPS(TTM)4.09
EY3.64%
EPS(NY)4.92
Fwd EY4.37%
FCF(TTM)3.28
FCFY2.91%
OCF(TTM)4.4
OCFY3.91%
SpS20.83
BVpS24.01
TBVpS9.44
PEG (NY)2.37
PEG (5Y)3.63
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.58% | ||
| ROE | 27.66% | ||
| ROCE | 10.8% | ||
| ROIC | 9.27% | ||
| ROICexc | 10.3% | ||
| ROICexgc | 19.85% | ||
| OM | 17.45% | ||
| PM (TTM) | 31.89% | ||
| GM | 56.1% | ||
| FCFM | 15.72% |
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
ROICexc(3y)12.18%
ROICexc(5y)11.89%
ROICexgc(3y)32.65%
ROICexgc(5y)35.03%
ROCE(3y)12.16%
ROCE(5y)11.86%
ROICexcg growth 3Y-24.08%
ROICexcg growth 5Y-8.19%
ROICexc growth 3Y-10.71%
ROICexc growth 5Y6.04%
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
F-Score7
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 1.99 | ||
| Debt/EBITDA | 1.21 | ||
| Cap/Depr | 72.36% | ||
| Cap/Sales | 5.42% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 84.75% | ||
| Profit Quality | 49.3% | ||
| Current Ratio | 1.78 | ||
| Quick Ratio | 1.27 | ||
| Altman-Z | 5.99 |
F-Score7
WACC8.69%
ROIC/WACC1.07
Cap/Depr(3y)63.63%
Cap/Depr(5y)61.92%
Cap/Sales(3y)4.94%
Cap/Sales(5y)5.1%
Profit Quality(3y)82.78%
Profit Quality(5y)99.6%
High Growth Momentum
Growth
EPS 1Y (TTM)8.88%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%11.22%
EPS Next Y11.61%
EPS Next 2Y10.91%
EPS Next 3Y10.72%
EPS Next 5Y9.82%
Revenue 1Y (TTM)5%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%3.95%
Revenue Next Year6.43%
Revenue Next 2Y7.08%
Revenue Next 3Y7.24%
Revenue Next 5Y7.19%
EBIT growth 1Y12%
EBIT growth 3Y-6.62%
EBIT growth 5Y8.41%
EBIT Next Year29.19%
EBIT Next 3Y15.9%
EBIT Next 5Y10.98%
FCF growth 1Y-2.43%
FCF growth 3Y-9.78%
FCF growth 5Y7.14%
OCF growth 1Y3.36%
OCF growth 3Y-6.69%
OCF growth 5Y6.88%